MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

Brigitte Dreno, John F Thompson, Bernard Mark Smithers, Mario Santinami, Thomas Jouary, Ralf Gutzmer, Evgeny Levchenko, Piotr Rutkowski, Jean-Jacques Grob, Sergii Korovin, Kamil Drucis, Florent Grange, Laurent Machet, Peter Hersey, Ivana Krajsova, Alessandro Testori, Robert Conry, Bernard Guillot, Wim H J Kruit, Lev Demidov, John A Thompson, Igor Bondarenko, Jaroslaw Jaroszek, Susana Puig, Gabriela Cinat, Axel Hauschild, Jelle J Goeman, Hans C van Houwelingen, Fernando Ulloa-Montoya, Andrea Callegaro, Benjamin Dizier, Bart Spiessens, Muriel Debois, Vincent G Brichard, Jamila Louahed, Patrick Therasse, Channa Debruyne, John M Kirkwood

Open source

DOI: 10.1016/s1470-2045(18)30254-7
Published: 2018-07
Container: The Lancet Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-18-30254-7,
  title = {MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial},
  author = {Brigitte Dreno and John F Thompson and Bernard Mark Smithers and Mario Santinami and Thomas Jouary and Ralf Gutzmer and Evgeny Levchenko and Piotr Rutkowski and Jean-Jacques Grob and Sergii Korovin and Kamil Drucis and Florent Grange and Laurent Machet and Peter Hersey and Ivana Krajsova and Alessandro Testori and Robert Conry and Bernard Guillot and Wim H J Kruit and Lev Demidov and John A Thompson and Igor Bondarenko and Jaroslaw Jaroszek and Susana Puig and Gabriela Cinat and Axel Hauschild and Jelle J Goeman and Hans C van Houwelingen and Fernando Ulloa-Montoya and Andrea Callegaro and Benjamin Dizier and Bart Spiessens and Muriel Debois and Vincent G Brichard and Jamila Louahed and Patrick Therasse and Channa Debruyne and John M Kirkwood},
  year = {2018},
  journal = {The Lancet Oncology},
  doi = {10.1016/s1470-2045(18)30254-7},
  url = {https://doi.org/10.1016/s1470-2045(18)30254-7}
}

RIS

TY  - JOUR
TI  - MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
AU  - Brigitte Dreno
AU  - John F Thompson
AU  - Bernard Mark Smithers
AU  - Mario Santinami
AU  - Thomas Jouary
AU  - Ralf Gutzmer
AU  - Evgeny Levchenko
AU  - Piotr Rutkowski
AU  - Jean-Jacques Grob
AU  - Sergii Korovin
AU  - Kamil Drucis
AU  - Florent Grange
AU  - Laurent Machet
AU  - Peter Hersey
AU  - Ivana Krajsova
AU  - Alessandro Testori
AU  - Robert Conry
AU  - Bernard Guillot
AU  - Wim H J Kruit
AU  - Lev Demidov
AU  - John A Thompson
AU  - Igor Bondarenko
AU  - Jaroslaw Jaroszek
AU  - Susana Puig
AU  - Gabriela Cinat
AU  - Axel Hauschild
AU  - Jelle J Goeman
AU  - Hans C van Houwelingen
AU  - Fernando Ulloa-Montoya
AU  - Andrea Callegaro
AU  - Benjamin Dizier
AU  - Bart Spiessens
AU  - Muriel Debois
AU  - Vincent G Brichard
AU  - Jamila Louahed
AU  - Patrick Therasse
AU  - Channa Debruyne
AU  - John M Kirkwood
PY  - 2018
JO  - The Lancet Oncology
DO  - 10.1016/s1470-2045(18)30254-7
UR  - https://doi.org/10.1016/s1470-2045(18)30254-7
ER  -

APA

Dreno, B., Thompson, J. F., Smithers, B. M., Santinami, M., Jouary, T., Gutzmer, R., Levchenko, E., Rutkowski, P., Grob, J., Korovin, S., Drucis, K., Grange, F., Machet, L., Hersey, P., Krajsova, I., Testori, A., Conry, R., Guillot, B., Kruit, W. H. J., Demidov, L., Thompson, J. A., Bondarenko, I., Jaroszek, J., Puig, S., Cinat, G., Hauschild, A., Goeman, J. J., Houwelingen, H. C. V., Ulloa-Montoya, F., Callegaro, A., Dizier, B., Spiessens, B., Debois, M., Brichard, V. G., Louahed, J., Therasse, P., Debruyne, C., & Kirkwood, J. M. (2018). MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(18)30254-7

Source records

crossref · retrieved 2026-09-26T20:00:02.436Z